Regions of the Lipopolysaccharide of Pseudomonas Aeruginosa Essential for Antitumor and Interferon-inducing Activities
Overview
Authors
Affiliations
Resistance against ascites tumor development and interferon-inducing activity were demonstrated in lipopolysaccharide derived from the protein-lipopolysaccharide complex obtained from an autolysate of Pseudomonas aeruginosa. Lipid A obtained from the lipopolysaccharide was sufficient to induce interferon in vitro but no antitumor activity was found if lipid A or the polysaccharide derived from lipopolysaccharide was injected into the animal. Chemical modification of the polysaccharide portion or deacylation of the lipopolysaccharide also diminished antitumor activity. In contrast, interferon was induced by these incomplete lipopolysaccharides. These results indicate that both the lipid A portion and covalently linked polysaccharide are necessary for the inhibition of ascites tumor development, whereas incomplete lipid A with amide-linked fatty acids is sufficient to induce interferon in vitro.
Mediated Necroptosis in Mouse Tumor Cells Induces Long-Lasting Systemic Antitumor Immunity.
Qi J, He J, Jin S, Yang X, Bai H, Liu C Front Oncol. 2021; 10:610651.
PMID: 33643911 PMC: 7908819. DOI: 10.3389/fonc.2020.610651.
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.
Vacchelli E, Galluzzi L, Eggermont A, Fridman W, Galon J, Sautes-Fridman C Oncoimmunology. 2012; 1(6):894-907.
PMID: 23162757 PMC: 3489745. DOI: 10.4161/onci.20931.
Tanamoto K Infect Immun. 1999; 67(7):3399-402.
PMID: 10377118 PMC: 116523. DOI: 10.1128/IAI.67.7.3399-3402.1999.
Tanamoto K, Zahringer U, McKenzie G, Galanos C, Rietschel E, LUDERITZ O Infect Immun. 1984; 44(2):421-6.
PMID: 6715042 PMC: 263535. DOI: 10.1128/iai.44.2.421-426.1984.
Hancock R, Mutharia L, Chan L, Darveau R, Speert D, Pier G Infect Immun. 1983; 42(1):170-7.
PMID: 6413410 PMC: 264539. DOI: 10.1128/iai.42.1.170-177.1983.